$Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available$
QR Code

Phase I study of the anti-VEGFR-3 monoclonal antibody IMC-3C5 in subjects with advanced solid tumors refractory to standard therapy or for which no standard therapy is available

Abstract only

Saved in:

Bibliographic Details
Published in:	Journal of clinical oncology Vol. 29; no. 15_suppl; p. TPS150
Main Authors:	Martell, R. E., Chiorean, E. G., Youssoufian, H., Rutstein, M. D., Pytowski, B., Benjamin, L., Abad, L., Patel, J., Steele, T., Dowd, M., Qin, A., Kukel, C. F., Fox, F. E., Dontabhaktuni, A., Morozov, A.
Format:	Journal Article
Language:	English
Published:	20-05-2011
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract only
ISSN:	0732-183X 1527-7755
DOI:	10.1200/jco.2011.29.15_suppl.tps150